EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a multivariate predictive model for dapsone adverse drug events in people with leprosy under standard WHO multidrug therapy

Ana Carolina Galvão Dos Santos de Araujo iD, Mariana de Andrea Vilas-Boas Hacker, Roberta Olmo Pinheiro, Ximena Illarramendi, Sandra Maria Barbosa Durães, Maurício Lisboa Nobre, Milton Ozório Moraes, Anna Maria Sales, Gilberto Marcelo Sperandio da Silva

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0011901 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Ana Carolina Galvão Dos Santos de Araujo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (INI/Fiocruz), Rio de Janeiro, RJ, Brazil. Hauptthemen laut MEDLINE: Leprosy, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Fundação Oswaldo Cruz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The occurrence of adverse drug events (ADEs) during dapsone (DDS) treatment in patients with leprosy can constitute a significant barrier to the successful completion of the standardized therapeutic regimen for this disease. Well-known DDS-ADEs are hemolytic anemia, methemoglobinemia, hepatotoxicity, agranulocytosis, and hypersensitivity reactions. Identifying risk factors for ADEs before starting World Health Organization recommended standard multidrug therapy (WHO/MDT) can guide therapeutic planning for the patient. The objective of this study was to develop a predictive model for DDS-ADEs in patients with leprosy receiving standard WHO/MDT. Methodology This is a case-control study that involved the review of medical records of adult (≥18 years) patients registered at a Leprosy Reference Center in Rio de Janeiro, Brazil. The cohort included individuals that received standard WHO/MDT between January 2000 to December 2021. A prediction nomogram was developed by means of multivariable logistic regression (LR) using variables. The Hosmer–Lemeshow test was used to determine the model fit. Odds ratios (ORs) and their respective 95% confidence intervals (CIs) were estimated. The predictive ability of the LRM was assessed by the area under the receiver operating characteristic curve (AUC).

Results

A total of 329 medical records were assessed, comprising 120 cases and 209 controls. Based on the final LRM analysis, female sex (OR = 3.61; 95% CI: 2.03–6.59), multibacillary classification (OR = 2.5; 95% CI: 1.39–4.66), and higher education level (completed primary education) (OR = 1.97; 95% CI: 1.14–3.47) were considered factors to predict ADEs that caused standard WHO/MDT discontinuation. The prediction model developed had an AUC of 0.7208, that is 72% capable of predicting DDS-ADEs.

Conclusion

We propose a clinical model that could become a helpful tool for physicians in predicting ADEs in DDS-treated leprosy patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeprosyDrug-Related Side Effects and Adverse ReactionsAdultHumansFemaleDapsoneLeprostatic AgentsRifampinDrug Therapy, CombinationCase-Control StudiesClofazimineBrazilWorld Health Organization

Substanzen

DapsoneLeprostatic AgentsRifampinClofazimine

Autor:innen und Institutionen

  • Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (INI/Fiocruz), Rio de Janeiro, RJ, Brazil.
  • Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC/Fiocruz), Rio de Janeiro, RJ, Brazil.
  • Dermatology Department, Fluminense Federal University (UFF), Niterói, RJ, Brazil.
  • Giselda Trigueiro Hospital, Rio Grande do Norte Federal State Public Health department (SESAP-RN), Natal, RN, Brazil.

ORCID-Profile: Ana Carolina Galvão Dos Santos de Araujo

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Fundação Oswaldo Cruz

Zitieren

APA

de Araujo, A. C. G. D. S., Hacker, M. A. V., Pinheiro, R. O., Illarramendi, X., Durães, S. M. B., Nobre, M. L., Moraes, M. O., Sales, A. M., & da Silva, G. M. S. (2024). Development of a multivariate predictive model for dapsone adverse drug events in people with leprosy under standard WHO multidrug therapy. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011901

Vancouver

de Araujo ACGDS, Hacker MAV, Pinheiro RO, Illarramendi X, Durães SMB, Nobre ML, et al. Development of a multivariate predictive model for dapsone adverse drug events in people with leprosy under standard WHO multidrug therapy. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0011901

BibTeX
@article{deAraujo2024,
  author = {de Araujo, Ana Carolina Galvão Dos Santos and Hacker, Mariana de Andrea Vilas-Boas and Pinheiro, Roberta Olmo and Illarramendi, Ximena and Durães, Sandra Maria Barbosa and Nobre, Maurício Lisboa and Moraes, Milton Ozório and Sales, Anna Maria and da Silva, Gilberto Marcelo Sperandio},
  title = {Development of a multivariate predictive model for dapsone adverse drug events in people with leprosy under standard WHO multidrug therapy},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0011901}
}
Kostenlos starten →